Houlden, Robyn L. http://orcid.org/0000-0002-2748-4741
Thayalan, Nilasha
Shi, Scott
Kukaswadia, Atif
Mau, Godfrey
Liu, Aiden
Funding for this research was provided by:
Novo Nordisk Canada
Article History
Received: 22 November 2023
Accepted: 16 January 2024
First Online: 10 February 2024
Declarations
:
: Dr. Houlden reports personal fees from Eli Lilly, personal fees from Novo Nordisk, personal fees from Dexcom, personal fees from Medtronic, personal fees from Boehringer Ingelheim, personal fees from Insulet, personal fees from Abbott, and personal fees from CPD Network, outside the submitted work. Dr. Thayalan has nothing to disclose. Scott Shi and Atif Kukaswadia are consultants employed by IQVIA Solutions Canada Inc to support this Novo Nordisk Canada Inc sponsored study. Godfrey Mau is an employee of Novo Nordisk Canada Inc, and Aiden Liu is an employee of Novo Nordisk A/S.
: This study was created using ethical principles that have their origins in the Declaration of Helsinki and applicable privacy laws. It was approved by Advarra IRB Services (IRB approvals Pro00049255 and Pro00039416). Analyses were conducted by an ICES analyst, using the analysis plan developed by the study authors.